IDENTIFICATION OF ANEMIA SYNDROME IN URBAN AND RURAL LEUKEMIA PATIENTS IN DYNAMICS FOR 2019-2023
Abstract
Iron deficiency anemia (IDA) is often associated with various chronic diseases, including oncological and oncohematological diseases (leukemia, multiple myeloma, myelodysplastic syndrome, etc.) (1,4,5). According to the World Health Organization (WHO), about 1.62 billion people on the planet suffer from various pathogenetic variants of anemia. IDA accounts for 80% of all forms of anemia in adults [2,3]. The pathogenesis of anemia in chronic diseases (ACD) is associated with iron metabolism, which changes due to an increase in the level of hepcidin, which inhibits the absorption and recirculation of iron. As a result, iron absorption in the duodenum and small intestine decreases, iron recirculation is impaired [8]. The development of anemic syndrome and iron metabolism in patients with hemoblastoses, and in particular leukemia, have been insufficiently studied and have conflicting opinions (2,3).
Keywords
Anemic syndrome, hematology, oncological, iron, leukemia, metabolism.How to Cite
References
1. Suleimanova D.N., Turabov A.Z, Zoirov G.Z., Asrarova N.M., Akbarova R.K., Ulugova Sh.T. Efficiency of parenteral ferrotherapy in patients with anemia of chronic diseases and iron deficiency anemia. The multidisciplinary journal jf aciece and tehnologi ISSN: 2582-4686 SJIF 2021-3.261,SJIF 2022-2.889, 2023-5.384 ResearchBib IF: 8.848 / 2024 - VOLUME-4, SSUE-10.
2. Ulugova Sh.T., Islamov M.S., Suleimanova D.N. The causes of leukemia are anemia. Journal of Humanitarian and Natural Sciences. ISS: 2181 – 4007 №5(10), 2024.Vol.1. pp. 258-261
3. Ulugova Sh.T., Islamov M.S., Suleimanova D.N. Indicators of anemic syndrome in primary patients with leukemia depending on profession and nationality. Journal of Humanitarian and Natural Sciences. ISS: 2181 – 4007 №5(10), 2024.Vol.1. pp. 255-258.
4. Khalilova N.A., Trapeznikova A.Yu., Shestakova M.D. Iron deficiency anemia in the structure of chronic diseases. https//o3,gpmu.org/index.php/childmed/frticle/view/5725/ 10.10.2024, p,10
5.khmerzaeva Z.Kh.1, Parovichnikova E.N.1, Rusinov M.A.1, Zotina E.N. 2, Gavrilova L.V. 3, Pristupa A.S.4, THE EPIDEMIOLOGICAL STUDY OF ACUTE LEUKEMIA IN FIVE REGIONS OF THE RUSSIAN FEDERATION Hematology and Transfusiology. 2017; 62(1) Original article, DOI http://dx.doi.org/10.18821/0234-5730-2017-62-1-46-51
6. Santos F.P., Alvarado Y., Kantarjian H. et al. Long-term prognostic impact of the use of
erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib // Cancer. – 2011. - Vol.117. - P.982–991.
7. Truong P.T., Parhar T., Hart J. et al. Population-based analysis of the frequency of anemia and
its management before and during chemotherapy in patients with malignant lymphoma // Am. J. Clin. Oncol. - 2010. - Vol.33. - P.465-468.
8. Santosh H.N., Nagaraj T., Sasidaran A. Anemia of chronic disease: A comprehensive review //Journal of Medicine, Radiology, Pathology & Surgery.- 2015.- Vol. 1.-R.13-16
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
